GSVTX | VIVIX | GSVTX / VIVIX | |
Total Expense Ratio | 0.75 | 0.04 | 1,875% |
Annual Report Gross Expense Ratio | 1.00 | 0.04 | 2,500% |
Fund Existence | 18 years | 27 years | - |
Gain YTD | 5.260 | 6.215 | 85% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 440M | 189B | 0% |
Annual Yield % from dividends | 1.26 | 2.19 | 57% |
Returns for 1 year | 2.27 | 12.05 | 19% |
Returns for 3 years | 18.49 | 35.17 | 53% |
Returns for 5 years | 36.39 | 80.14 | 45% |
Returns for 10 years | 5.57 | 115.68 | 5% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 130.00 | 0.45 | +0.35% |
iShares Biotechnology ETF | |||
GHY | 13.64 | 0.02 | +0.15% |
PGIM Global High Yield Fund | |||
XB | 39.58 | 0.03 | +0.08% |
BondBloxx B Rated USD Hi Yld Corp Bd ETF | |||
JUNM | 33.30 | 0.01 | +0.04% |
FT Vest U.S. Equity Max Bffr ETF - June | |||
FLUD | 24.96 | -0.02 | -0.08% |
Franklin Ultra Short Bond ETF |